Spots Global Cancer Trial Database for a2a
Every month we try and update this database with for a2a cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
TT-10 as a Single Agent in Subjects With Advanced Selected Solid Tumors | NCT04969315 | Renal Cell Canc... Castrate Resist... Non Small Cell ... Head and Neck S... | TT-10 | 18 Years - | Portage Biotech | |
Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer | NCT05177770 | Metastatic Cast... Prostate Cancer | SRF617 etrumadenant zimberelimab | 18 Years - | Coherus Biosciences, Inc. | |
Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer | NCT05177770 | Metastatic Cast... Prostate Cancer | SRF617 etrumadenant zimberelimab | 18 Years - | Coherus Biosciences, Inc. | |
TT-10 as a Single Agent in Subjects With Advanced Selected Solid Tumors | NCT04969315 | Renal Cell Canc... Castrate Resist... Non Small Cell ... Head and Neck S... | TT-10 | 18 Years - | Portage Biotech |